References
- Barackman JD , OttG, O‘HaganDT. Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization. Infect. Immun.67, 4276–4279 (1999).
- Upadhyay S , ParikhA, JoshiP, UpadhyayUM, ChotaiNP. Intranasal drug delivery system. A glimpse to become maestro. J. App. Pharm. Sci.1, 34–44 (2011).
- Holmgren J , CzerkinskyC. Mucosal immunity and vaccines. Nat. Med.11, S45–S53 (2005).
- Jadhav KR , GambhireMN, ShaikhIM, KadamVJ, PisalSS. Nasal drug delivery system-factors affecting and applications. Curr. Drug Ther.2, 27–38 (2007).
- Kang ML , ChoCS, YooHS. Application of chitosan microspheres for nasal delivery of vaccines. Biotech. Adv.27, 857–865 (2009).
- Atmar RL , KeitelWA, CateTR, MunozFM, RubenF, CouchRB. A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. Vaccine25, 5367–5373 (2007).
- Chen WX , PatelGB, YanHB, ZhangJB. Recent advances in the development of novel mucosal adjuvants and antigen delivery systems. Human Vaccines6, 706–714 (2010).
- Türker S , OnurE, OzerY. Nasal route and drug delivery systems. Pharm. World Sci.26, 137–142 (2004).
- Bergquist C , Johansson E-L, Lagergård T, Holmgren J, Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun.65, 2676–2684 (1997).
- Adeola OA , AdenijiJA, OlugasaBO. Detection of haemagglutination-inhibitingantibodies against human H1 and H3 strains of influenza A viruses in pigs inIbadan, Nigeria. Zoonoses Public Health57, e89–e94 (2010).
- Alsarra IA , HamedAY, MahrousGM, EI Maghraby GM, Al-Robayan AA, Alanazi FK. Mucoadhesive polymeric hydrogels for nasal delivery of acyclovir. Drug Dev. Ind. Pharm.35, 352–362 (2009).
- Alsarra IA , HamedAY, AlanaziFK, NeauSH. Rheological and mucoadhesive characterization of poly(vinylpyrrolidone) hydrogels designed for nasal mucosal drug delivery. Arch. Pharma. Res.34, 573–582 (2011).
- Wu J , WeiW, WangLY, SuZG, MaGH. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system. Biomaterials28, 2220–2232 (2007).
- Wu YB , WeiW, ZhouM, WuJ, MaGH, SuZG. Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization. Biomaterials33, 2351–2360 (2012).
- Wu YB , WuSP, HouLH et al. Novel thermal-sensitive hydrogel enhances both humoral and cell-mediated immune responses by intranasal vaccine delivery. Eur. J. Pharm.Biopharm.81(3), 486–497 (2012).
- Karczewski J , TroostFJ, KoningsIet al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G851–G859 (2010).